Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity

The psychotropic amphetamine derivatives 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA) have been used for recreational and therapeutic purposes in man. In rats, these drugs cause large reductions in brain levels of serotonin (5-HT). This study employs immunocytoche...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurosci
Egile Nagusiak: O'Hearn, E, Battaglia, G, De Souza, EB, Kuhar, MJ, Molliver, ME
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Neuroscience 1988
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6569396/
https://ncbi.nlm.nih.gov/pubmed/2457659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.08-08-02788.1988
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak